L. Vignali, F. Cialdai, M. Monici.
Energy for Health [07]:12-18, 2011
Laser is widely used in many medical fields and its effects are reported by several studies in literature. Very important are the applications in sports medicine, physical medicine and rehabilitation, based on the analgesic, anti-inflammatory and anti-oedema effects of laser therapy, as well as the stimulating action on tissue repair processes. In our study, we analyzed the effects of an advanced laser system, the Multiwave Locked System (MLS), on myoblasts in order to evaluate the effectiveness of this laser in promoting recovery of damaged muscle tissue. The MLS device consists of two synchronized diodes emitting at 808 and 905 nm, respectively. C2C12 murine myoblasts cell line was used as experimental model since it is a widely accepted model in muscle cells behavior studies. Viability and proliferation was assessed after a single treatment as well as after 4 consecutive treatment (1 treatment/day). No significant changes were observed in viability, while proliferation decreased after 4 treatments. Moreover, we found an increased expression of MyoD, a key factor in myoblasts maturation. Changes in cytoskeleton organization, in particular the networks of actin microfilaments and microtubules, were also observed. Decresed proliferation rate, increased MyoD expression and cytoskeleton rearrangement are consistent with myoblast differentiation. Finally the expression of molecules involved in the regulation of extracellular matrix (EC M) turnover (collagen I, MMP-2, MMP-9) was analyzed. After 4 treatments, collagen I expression showed a 14% increase while MMP-2 and MMP-9 decreased of 33% and 18%, respectively. These results suggest that MLS treatment could affect EC M turnover shifting the balance toward the production rather than to the degradation. In conclusion, our findings demonstrate that MLS treatment induces in muscle cells a biological response that could favour muscle cell differentiation and the recovery of diseased muscle tissue. A deeper knowledge of the mechanisms underlying the effects described above and a greater understanding of the changes in the biological response to variations in instrumental parameters setting can lead to concrete improvements in treatment protocols.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.